Company / R&D per Share
Adaptive Biotechnologies Corp R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.63
FY2025
5-year range
$0.63 / $1.03
FY2021-FY2025
Trend
-10.6%
vs FY2024
Sector context
#167 of 208
Health Care
What the data says
Adaptive Biotechnologies Corp's r&d per share of $0.63 is lower than 80% of companies in the Health Care sector (FY2025). R&D per Share has declined for 4 consecutive years, from $1.03 in FY2021 to $0.63 in FY2025.
Based on SEC 10-K filings.
0.63 in FY2025 with a 5-year CAGR of -7.3%.
Declined from $0.85 to $0.63 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -14.1%
- 5-Year CAGR
- -7.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 208This company $0.63 Sector average $12.19
▼
-94.8% below sector average
Key checks
Key Insights
- Adaptive Biotechnologies Corp's r&d per share has declined for 4 consecutive years.
- In FY2025, r&d per share decreased 10.6% year-over-year.
- Ranks #167 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.63 | -10.6% |
| FY2024 | $0.71 | -16.8% |
| FY2023 | $0.85 | -14.9% |
| FY2022 | $1.00 | -3.1% |
| FY2021 | $1.03 | +11.6% |
| FY2020 | $0.93 | -83.2% |
| FY2019 | $5.51 | +77.6% |
| FY2018 | $3.10 | +18.2% |
| FY2017 | $2.62 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026